Babbage from The Economist

Share

Babbage: The scandal of scientific fraud

There is a worrying amount of fraud in medical research. As many as one in 50 research papers may be unreliable because of fabrication, plagiarism or serious errors. Fabricated data can influence the guidelines which doctors use to treat patients. Misguided clinical guidelines could cause serious illness and death in patients. Fraudulent studies can also influence further research programmes—recent findings suggest that manipulated images may have resulted in scientists wasting time and money following blind alleys in Alzheimer’s research for decades. What can be done to combat scientific malpractice? 


Dorothy Bishop, a retired professor of psychology at the University of Oxford, explores the motivation behind fraudsters in research. John Carlisle, an anaesthetist and an editor of the journal Anaesthesia, explains the impact of fraud and how to detect it in research papers. Also, Elisabeth Bik, a former microbiologist and a full-time scientific image detective, discusses the consequences of whistle-blowing on both sleuths and the fraudsters. Plus, The Economist’s health-care correspondent, Slavea Chankova, investigates how to overcome the worrying unwillingness on all sides to do anything about fraud in research. Alok Jha hosts.


For full access to The Economist’s print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience.

More Episodes

Wednesday, May 17, 2023

Babbage: How to battle superbugs with viruses

Antimicrobial resistance killed over a million people in 2019. That figure is expected to rise to ten million by 2050. Antibiotics remain vital to modern medicine, but this hidden pandemic of drug-resistant superbugs is driving scientists to explore possible alternatives. One type of therapy in particular is attracting serious scientific interest: bacteriophages. Phages are viruses that can destroy bacteria. In the 1920s, phage therapies were used widely against infections, but much of the world abandoned the idea following the discovery of penicillin. Some parts of the former Soviet Union, though, have continued to use phage therapies. What can governments and international companies learn from this medicine?Gilead Amit, The Economist’s science correspondent, travels to the Eliava Institute in Tbilisi, Georgia to find out how phage therapies have been used there over the last century. He speaks to the director, Mzia Kutateladze, head of phage production, Vakho Pavlenishvili, and from the therapy centre: Davit Sturia, Lia Nadareishvili and Lana Abesadze. Barry Rud, a Canadian patient attending the clinic, discusses his experience. Steffanie Strathdee, who leads phage research at the University of California, San Diego, explains the renewed international interest in bacteriophages. Alok Jha, The Economist’s science and technology editor, hosts.We would love to hear from you. Please fill out our listener survey at economist.com/babbagesurvey.The Economist is also seeking applications for the 2023 Richard Casement internship. The successful candidate will spend three months with us in London writing about science and technology. More details here: economist.com/casement2023.For full access to The Economist’s print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience.
Wednesday, May 10, 2023

Babbage: How drones are transforming warfare in Ukraine

The use of drones in the war in Ukraine has been increasing. Unmanned vehicles capture battlefield images, relay co-ordinates, and strike targets in Ukraine and even Russia. Whether purpose-built military devices or off-the-shelf civilian technology, the drones are having an outsized impact. How are they influencing battles? And what do they mean for the future of warfare?Oliver Carroll, our correspondent in Ukraine, explores the purpose and effectiveness of drones in the war. Ulrike Franke of the European Council on Foreign Relations explains the potential that drone technology offers to armies. Plus, The Economist’s Benjamin Sutherland travels to Kyiv, to investigate how engineers in underground workshops are tinkering with consumer drones and turning them into military machines. Alok Jha, The Economist’s science and technology editor, hosts.  If you love Babbage, why not work with us? We’re hiring for an Assistant Audio Producer to work on the show. Apply by May 15th.The Economist is also seeking applications for the 2023 Richard Casement internship. The successful candidate will spend three months with us in London writing about science and technology. More details here: economist.com/casement2023.For full access to The Economist’s print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our weekly science newsletter at economist.com/simplyscience.